Immunogenicity and safety of an investigational tetravalent recombinant subunit vaccine for dengue: results of a Phase I randomized clinical trial in flavivirus-naïve adults. [electronic resource]
Producer: 20200303Description: 2195-2204 p. digitalISSN:- 2164-554X
- Adjuvants, Immunologic -- administration & dosage
- Adolescent
- Adult
- Antibodies, Neutralizing -- blood
- Antibodies, Viral -- blood
- Dengue -- prevention & control
- Dengue Vaccines -- administration & dosage
- Dengue Virus
- Drug Compounding
- Female
- Humans
- Immunization Schedule
- Immunogenicity, Vaccine
- Male
- Middle Aged
- Neutralization Tests
- Proof of Concept Study
- Vaccines, Subunit -- administration & dosage
- Vaccines, Synthetic -- administration & dosage
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.